// App-Quantinova.ai

: Can a 9‐item Modified Villalta Score Adequately Predict Post Thrombotic Syndrome? A Subgroup Analysis from the ‘Follow‐up in Rivaroxaban Patients in Setting of Thromboembolism’ (FIRST) Registry

Researchers

Presenter

  • V. Speed

Principal Investigators

  • L. Roberts

  • J. Patel

  • R. Patel

  • R. Arya

Medical Centers

  • Kings College London, London, United Kingdom

  • King's College London, Institute of Pharmaceutical Science, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

Disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • rivaroxaban

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved